Abstract
Microglia are crucial mediators of brain development and homeostasis. In recent years, it has been additionally suggested that modulation of microglial function may prove to be a useful therapeutic technique in many neurological contexts. However, before we can develop therapeutics, we need to better understand homeostatic microglial processes at the cellular and molecular level. For this reason, it has become crucial to develop better models to study human microglia which are known to be quite distinct from murine models. Here we provide a detailed method to differentiate homeostatic microglia from human pluripotent cells. Additionally, due to the innate sensitivity of these immune cells, we have provided detailed notes for best practices of handling cultured microglia.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Andrews SJ, Fulton-Howard B, Goate A (2020) Interpretation of risk loci from genome-wide association studies of Alzheimer’s disease. Lancet Neurol 19(4):326–335. https://doi.org/10.1016/S1474-4422(19)30435-1
Efthymiou AG, Goate AM (2017) Late onset Alzheimer’s disease genetics implicates microglial pathways in disease risk. Mol Neurodegener 12(1):43. https://doi.org/10.1186/s13024-017-0184-x
Cowan M, Petri WA (2018) Microglia: immune regulators of neurodevelopment. Front Immunol 9:2576. https://doi.org/10.3389/fimmu.2018.02576
Abud EM et al (2017) iPSC-derived human microglia-like cells to study neurological diseases. Neuron 94(2):278–293.e9. https://doi.org/10.1016/j.neuron.2017.03.042
Douvaras P et al (2017) Directed differentiation of human pluripotent stem cells to microglia. Stem Cell Reports 8(6):1516–1524. https://doi.org/10.1016/j.stemcr.2017.04.023
Haenseler W, Rajendran L (2019) Concise review: modelling neurodegenerative diseases with human pluripotent stem cell derived microglia. Stem Cells 37(6):724–730. https://doi.org/10.1002/stem.2995
McQuade A, Coburn M, Tu CH, Hasselmann J, Davtyan H, Blurton-Jones M (2018) Development and validation of a simplified method to generate human microglia from pluripotent stem cells. Mol Neurodegener 13(1):67. https://doi.org/10.1186/s13024-018-0297-x
Muffat J et al (2016) Efficient derivation of microglia-like cells from human pluripotent stem cells. Nat Med 22(11):1358–1367. https://doi.org/10.1038/nm.4189
Pandya H et al (2017) Differentiation of human and murine induced pluripotent stem cells to microglia-like cells. Nat Neurosci 20(5):753–759. https://doi.org/10.1038/nn.4534
Takata K et al (2017) Induced-pluripotent-stem-cell-derived primitive macrophages provide a platform for modeling tissue-resident macrophage differentiation and function. Immunity 47(1):183–198.e6. https://doi.org/10.1016/j.immuni.2017.06.017
Prinz M, Erny D, Hagemeyer N (2017) Ontogeny and homeostasis of CNS myeloid cells. Nat Immunol 18(4):385–392. https://doi.org/10.1038/ni.3703
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2021 Springer Science+Business Media, LLC
About this protocol
Cite this protocol
McQuade, A., Blurton-Jones, M. (2021). Human Induced Pluripotent Stem Cell-Derived Microglia (hiPSC-Microglia). In: Nagy, A., Turksen, K. (eds) Induced Pluripotent Stem (iPS) Cells. Methods in Molecular Biology, vol 2454. Humana, New York, NY. https://doi.org/10.1007/7651_2021_429
Download citation
DOI: https://doi.org/10.1007/7651_2021_429
Published:
Publisher Name: Humana, New York, NY
Print ISBN: 978-1-0716-2118-9
Online ISBN: 978-1-0716-2119-6
eBook Packages: Springer Protocols